Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Ashkin

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Science (New York, N.Y.)|September 25, 2020
Full disclosureEmily Ashkin, Michelle Atallah
Journal of the National Cancer Institute|December 22, 2017
The Effect of Topoisomerase I Inhibitors on the Efficacy of T-Cell-Based Cancer ImmunotherapyJodi A McKenzie, Rina M Mbofung, Shruti Malu, et al.
Nature Communications|September 8, 2017
HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genesRina M Mbofung, Jodi A McKenzie, Shruti Malu, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Science (New York, N.Y.)|September 25, 2020
Full disclosureEmily Ashkin, Michelle Atallah
Journal of the National Cancer Institute|December 22, 2017
The Effect of Topoisomerase I Inhibitors on the Efficacy of T-Cell-Based Cancer ImmunotherapyJodi A McKenzie, Rina M Mbofung, Shruti Malu, et al.
Nature Communications|September 8, 2017
HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genesRina M Mbofung, Jodi A McKenzie, Shruti Malu, et al.
Pageof 1